Company intelligence / Profile preview

Odin Pharmaceuticals

Somerset, New Jersey, United Statesodinpharmaceuticals.com ↗

Ownership: Private
Employees: ~35
Development stage: Other

Overview

Odin Pharmaceuticals develops, manufactures, and markets sterile injectable and ophthalmic generic drugs for the US healthcare market. The company focuses on difficult-to-develop or manufacture generics using advanced aseptic processing technologies. It has an expanding pipeline but does not disclose specific clinical results or product names publicly. No proprietary new chemical entities or clinical trial data are reported.

Therapeutic areas: OphthalmologyOther
Modalities: Small molecule (injectable generics)Biologic (potentially for sterile/ophthalmic products; not explicitly confirmed)Injectable drug products
Industry: Contract Manufacturing Organization

Partnerships

Relationships with major customers including retail pharmacies, hospitals, clinics, wholesalers, distributors, group purchasing organizations, government agencies

Beyond the preview

Go deeper on Odin Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Odin Pharmaceuticals.

Explore the full profile